High Stakes for Merck in Litigation on Fosamax
Thursday, September 3, 2009 - 12:28
in Health & Medicine
Merck spent $7 million in the second quarter to defend itself in the first of at least 900 pending cases in which plaintiffs claim that taking Fosamax caused jaw injuries.